News

CF Trust To Help Patients Learn Their CFTR Gene Mutation

UK-based non-profit organization, Cystic Fibrosis Trust, recently launched a new awareness campaign that seeks to empower individuals living with cystic fibrosis (CF) to find out which specific CFTR gene mutation they are carrying. When patients know their specific mutation, physicians can prescribe more targeted, effective treatments, and even help patients participate in appropriate clinical…

Harmonica Techs, Inventors of the Pulmonica, Reveal Survey Results on Effective Treatments for Cystic Fibrosis Patients

During the annual meeting of the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), medical device company Harmonica Techs asked health professionals dealing with cystic fibrosis and other pulmonary conditions if they observed that spirometry improves patients’ lung function through any of the standard interventions. In order to assess…

Cystic Fibrosis Foundation Highlights CF Focus in State of the Union Address as Model for Precision Medicine

President Barack Obama, during his recent State of the Union Address, highlighted cystic fibrosis (CF) as the nation’s model for the White House’s upcoming strengthened strategy for “precision medicine,” or groundbreaking treatments that specifically target “chinks” in a disease’s “armor” — commonly found all the way down to a…

Galapagos-UA Collaboration on New Antibiotic Research Receives €2.5 million grant

Galapagos NV, a Belgium-based, clinical stage biotech company focused on developing novel mode of action medicines, recently announced it has received a €2.5 million grant from the Flemish Agency for Innovation through Science and Technology (IWT), which is meant to fund the company’s further research and development of new antibiotics. Working…